The pharmaceutical company plans to cut $2 billion in annual expenses by the end of 2027 through “operational efficiencies ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

But there were also invisible treasures—assets you couldn’t touch but which added immense value to businesses. These were things like patents, copyrights, brand value, or software. Businesses ...

Corteva's genetically modified Enlist platform has had wins over Bayer in recent years in gaining approval for its GMO seeds to be imported into China, which should boost Enlist's market share.

The Madhya Pradesh government has formulated a new drone policy to foster manufacturing of drones in the state as well as ...

SALT LAKE CITY - Myriad Genetics , Inc. (NASDAQ: NASDAQ:MYGN), a company specializing in genetic testing and precision medicine with annual revenues of $824 million, has announced the issuance of two ...

Pursuant to the terms of the Indenture governing InterDigital's 3.50% Senior Convertible Notes due 2027 (the "Notes”), the Notes are convertible during its calendar quarter ending March 31, 2025. The ...

For a country like Korea, where both research talent and funding are scarce compared to AI superpowers, the prevailing assumption has been that it could do little more than watch from the sidelines.

BMS is not the only U.S. pharma giant making massive cuts. Last year, Pfizer revealed a similar plan to reduce $1.5 billion ...

As 2025 kicks off there’s lots of activity in the world of IP – particularly in the Biotech and Pharma sectors, writes Marc ...

An ambitious startup is creating glasses that take action on your behalf and provide real-time information based on your ...

Taylor Swift is definitely in her WAG era - and the pop star has a whole slew of vintage and designer outfits to show for it.